Lv4
480 积分 2022-12-02 加入
Actinium-225-PSMA radioligand therapy of metastatic castration-resistant prostate cancer (WARMTH Act): a multicentre, retrospective study
18小时前
已完结
Hemosiderotic Fibrolipomatous Tumor on FDG PET/CT
18天前
已完结
原发性肺印戒细胞癌18F－FDG PET/CT显像1例
19天前
已完结
177Lu-PSMA and 177Lu-DOTATATE Therapy in a Patient With Metastatic Castration-Resistant Prostate Cancer and Neuroendocrine Differentiation
19天前
已完结
Prostate Cancer With Neuroendocrine Differentiation Recurring After Treatment With 177Lu-PSMA: A Chance for 177Lu-DOTATATE Therapy?
19天前
已完结
Excellent Response to 177Lu-DOTATATE Peptide Receptor Radionuclide Therapy in a Patient With Progressive Metastatic Castration-Resistant Prostate Cancer With Neuroendocrine Differentiation After 177Lu-PSMA Therapy
19天前
已完结
Development of [225Ac]Ac‑LNC1011 for targeted alpha-radionuclide therapy of prostate cancer
28天前
已完结
Metabolic syndrome and cancer risk: A two-sample Mendelian randomization study of European ancestry
3个月前
已完结
68Ga-DOTA-FAPI-04 PET/CT imaging in radioiodine-refractory differentiated thyroid cancer (RR-DTC) patients
4个月前
已完结
[68Ga]Ga-LNC1007 versus 2-[18F]FDG in the evaluation of patients with metastatic differentiated thyroid cancer: a head-to-head comparative study
4个月前
已完结
皖公网安备34019202002308
